Biogen Wants MS Drug Approved Globally, CEO Says

April 15 (Bloomberg) -- George Scangos, chief executive officer of Biogen Idec Inc., talks about the drugmaker's first multiple sclerosis pill Tecfidera and the company's drug pipeline. He speaks with Betty Liu on Bloomberg Television's "In the Loop." (Source: Bloomberg)
It's Not the Right Time for Flipkart to Go Public: CFO
41:49 - Flipkart CFO Sanjay Baweja discusses the company's fundraising activity, the possibility of an IPO and the outlook for profitability with Bloomberg's Shery Ahn at the 2015 TechNet Conference in Hong Kong. (Source: Bloomberg)
  • Asia Can Do More With Wearable Tech Than U.S.: LeBoeuf
  • Jumei Co-CFO Says China Tariff Cut Has Minimum Impact
  • Euro Traders Shed Last Bit of Optimism